treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologus HSCT

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Fingerprint Entra nei temi di ricerca di 'treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologus HSCT'. Insieme formano una fingerprint unica.

Medicine & Life Sciences